Skip to main content

Advertisement

SpringerLink
Log in

Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Since the discovery of the hepatitis C virus (HCV), it has become evident that this infectious agent is a primary cause of posttransfusion and sporadic non-A, non-B hepatitis. Identification and introduction of surrogate markers for posttransfusion hepatitis and later introduction of anti-HCV screening has decreased the incidence of posttransfusion hepatitis. Community-acquired HCV infection is less common than posttransfusion HCV hepatitis. HCV infection may lead to liver cirrhosis without prior evidence of laboratory or histologic infection. Populations at risk for HCV infection include patients receiving organ transplants, health care workers, infants born to HCV-infected mothers, and hemodialysis patients. Intravenous drug abusers and their sexual partners also demonstrate a high rate of HCV infection. Nosocomial HCV transmission may occur despite the observance of universal precautions. Dental or surgical intervention, salivary inoculation, family members infected with HCV, cocaine abuse, HIV infection, and lower socioeconomic status also each correlate with an increased risk of infection. HCV infection is associated with many immune-mediated diseases. There may also be some relationship between human leukocyte antigens and HCV infection. Since there currently is no HCV vaccine, prevention of exposure remains the only possibility for reducing HCV transmission and prevalence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362, 1989

    Google Scholar 

  2. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Berger K, Shuster JR, Overby LR, Bradly W, Houghton M: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B viral hepatitis genome. Science 244:362–364, 1989

    Google Scholar 

  3. Van der Poel CL, Reesink HW, Lelie PN, Leentvaar-Kuypers A, Choo Q-L, Kuo G, Houghton M: Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 2:297–298, 1989

    Google Scholar 

  4. Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernández JM, Roget M, Vargas V, Genscá J, Briti M, Guardia J, Houghton M, Choo Q-L, Kuo G: Hepatitis C virus antibodies among risk groups in Spain. Lancet 2:294–297, 1989

    Google Scholar 

  5. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494–1500, 1989

    Google Scholar 

  6. Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo Q-L, Kuo G: Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 87:983–987, 1990

    Google Scholar 

  7. Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW: Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Br Med Bull 46:423–441, 1990

    Google Scholar 

  8. Esteban JI, González A, Hernández JM, Viladomiu L, Sánchez C, López-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, Guardia J: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107–1112, 1990

    Google Scholar 

  9. Aach RD, Stevens CE, Hollinger B, Mosely JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ: Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325:1325–1329, 1991

    Google Scholar 

  10. Feinman SV, Berris B, Herst R: Anti-HCV in post-transfusion hepatitis: Deductions from a prospective study. J Hepatol 12:377–381, 1991

    Google Scholar 

  11. Bortolotti F, Tagger A, Cadrobbi P, Crivellaro C, Pregliasco F, Ribero ML, Alberti A: Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis. J Hepatol 12:176–180, 1991

    Google Scholar 

  12. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ for the Sentinal Counties Chronic Non-A, Non-B Hepatitis Study Team: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899–1905, 1992

    Google Scholar 

  13. Fagan EA, Harrison TJ: Exclusion in liver by polymerase chain reaction of hepatitis B and C viruses in acute liver failure attributed to sporadic non-A, non-B hepatitis. J Hepatol 21:587–591, 1994

    Google Scholar 

  14. Mutimer D, Shaw J, Neuberger J, Skidmore S, Martin B, Hubscher S, McMaster P, Elias E: Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A, non-B hepatitis. Gut 36:433–436, 1995

    Google Scholar 

  15. Brillanti S, Masci C, Ricci P, Miglioli M, Barbara L: Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C. Hepatology 15:998–1001, 1992

    Google Scholar 

  16. Douglas DD, Rakela J, Taswell HF, Persin DH, Wilber J, Sanchez-Pescador R, Neuwald P, Urdea MS: Correlation of quantitative HCV RNA, anti-HCV IgM, and serum ALT with histologic presentation. Hepatology 16:201A, 1992 (abstract)

    Google Scholar 

  17. Jeffers LJ, Hasan F, De Medina M, Reddy R, Parker T, Silva M, Mendez L, Schiff ER, Manns M, Houghton M, Choo Q-L, Kuo G: Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology 15:187–190, 1992

    Google Scholar 

  18. Brown J, Dourakis S, Karayiannis P, Goldin R, Chiba J, Ohba H, Miyamura T, Thomas HC: Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease. Hepatology 15:175–179, 1992

    Google Scholar 

  19. Bortolotti F, Vajro P, Cadrobbi P, Lepore L, Zancan L, Barbera C, Crivellaro C, Fontanella A, Alberti A, D'Addezio M: Cryptogenic chronic liver disease and hepatitis C virus infection in children. J Hepatol 15:73–76, 1992

    Google Scholar 

  20. Brind AM, Codd AA, Cohen BJ, Gabriel FG, Collins JD, James OFW, Bassendine MF: Low prevalence of antibody to hepatitis C virus in north east England. J Med Virol 32:243–248, 1990

    Google Scholar 

  21. Mansell CJ, Locarnini SA: Epidemiology of hepatitis C in the East. Semin Liver Dis 15:15–32, 1995

    Google Scholar 

  22. Prohaska W, Wolff C, Lechler E, Kleesiek K: High rate of false positives in blood donor screening for antibodies to hepatitis C virus. Cause of underestimation of virus transmission rate? Klin Wochenschr 69:294–296, 1991

    Google Scholar 

  23. Widell A, Månsson A-S, Sundström G, Hansson BG, Nordenfelt E: Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol 35:253–258, 1991

    Google Scholar 

  24. Boxall E, Skidmore S, Evans C, Nightingale S: The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol Infect 113:523–528, 1994

    Google Scholar 

  25. Larsen J, Hetland G, Skaug K, Maeland A: Viral hepatitis and blood transfusion. Tidsskr Nor Laegeforen 111:825–828, 1991 (in Norwegian)

    Google Scholar 

  26. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, D'Amico E, Cambiè G, Vecchi L, and the Lombardi Study Group on Vertical HCV Transmission: Mother-to-infant transmission of hepatitis C virus. Lancet 345:289–291, 1995

    Google Scholar 

  27. Marcellin P, Bernuau J, Martinot-Peignoux M, Larzul D, Xu L-Z, Tran S, Bezeaud A, Guimont M-C, Levardon M, Aumont P, Erlinger S, Benhamou J-P: Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children. Dig Dis Sci 38:2151–2155, 1993

    Google Scholar 

  28. Roudot-Thoraval F, Pawlotsky J-M, Thiers V, Deforges L, Girollet P-P, Guillot F, Huraux C, Aumont P, Brechot C, Dhumeaux D: Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: A prospective study with hepatitis C virus RNA testing. Hepatology 17:772–777, 1993

    Google Scholar 

  29. Trautwein C, Kiral G, Tillmann HL, Witteler H, Michel G, Manns MP: Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union. J Med Virol 45:429–434, 1995

    Google Scholar 

  30. Lystar' BN, Skvortsov SV, Poliakova II, Lovanova VIu, Belov EV: Detection of antibodies to hepatitis C virus in blood donors. Gematol Transfuziol 38:29–31, 1993 (in Russian)

    Google Scholar 

  31. Ndumbe PM, Skalsky J, Joller-Jemelka HI: Seroprevalence of hepatitis and HIV infection among rural pregnant women in Cameroon. APMIS 102:662–666, 1994

    Google Scholar 

  32. Saleh MG, Pereira LMMB, Tibs CJ, Ziu M, Al-Fituri MO, Williams R, McFarlane IG: High prevalence of hepatitis C virus in normal Libyan population. Trans R Soc Trop Med Hyg 88:292–294, 1994

    Google Scholar 

  33. Darwish M, Faris R, Clemens J, Rao M, Edelman R: Hepatitis C virus. Lancet 345:190–191, 1995 (letter)

    Google Scholar 

  34. Abdelaal M, Rowbottom D, Zawawi T, Scott T, Gilpin C: Epidemiology of hepatitis C virus: A study of male blood donors in Saudi Arabia. Transfusion 34:135–137, 1994

    Google Scholar 

  35. Deseda CC, Sweeney PA, Woodruff BA, Lindegren ML, Shapiro CN, Onorato IM: Prevalence of hepatitis B, hepatitis C, and human immunodeficiency virus infection among women attending prenatal clinics in San Juan, Puerto Rico, from 1989–1990. Obstet Gynecol 85:75–78, 1995

    Google Scholar 

  36. Nkengasong JN, De Beenhouwer H, Claeys H, Nyambi P, Ayuk J, van der Groen G, Ndumbe P: A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern Cameroon. Am J Trop Med Hyg 52:98–100, 1995

    Google Scholar 

  37. Soni PN, Tait DR, Kenoyer DG, Fernandes-Costa F, Naicker S, Gopaul W, Simjee AE: Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 40:65–68, 1993

    Google Scholar 

  38. Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ: Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 21:196–200, 1993

    Google Scholar 

  39. Irving WL, Neal KR, Underwood JCE, Simmonds PN, James V, on behalf of Trent Regional Hepatitis C Virus Study Group: Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. Br Med J 308:695–696, 1994

    Google Scholar 

  40. Nordøy I, Schrumpf E, Elgjo K, Flesland Ø, Andersen Glende J, Ørjasæter H, Siebke J-C: Liver disease in anti-hepatitis C virus positive Norwegian blood donors. Scand J Gastroenterol 29:77–81, 1994

    Google Scholar 

  41. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A: Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 340:697–698, 1992

    Google Scholar 

  42. Kuboki M, Shinzawa H, Ishibashi M, Yoshii E, Takahashi T, Iinuma K: Hepatitis C virus infection and liver disease in ALT normal individuals with anti-HCV positive. Gastroenterology 104(suppl):A931, 1993 (abstract)

    Google Scholar 

  43. Brillanti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L: Persistent hepatitis C viraemia without liver disease. Lancet 341:464–465, 1993

    Google Scholar 

  44. Inoue Y, Takeuchi K, Chou W-H, Unayama T, Takahashi K, Saito I, Miyamura T: Silent mother-to-child transmission of hepatitis C virus through two generations determined by comparative nucleotide sequence analysis of the viral cDNA. J Infect Dis 166:1425–1428, 1992

    Google Scholar 

  45. Yuki N, Hayashi N, Takehara T, Hagiwara H, Hiramatsu N, Naito M, Kawanishi Y, Katayama K, Kasahara A, Fusamoto H, Kamada T: Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors. Am J Gastroenterol 89:1462–1466, 1994

    Google Scholar 

  46. Mathiesen UL, Ekermo B, Foberg U, Franzén L, Frydén A, Norlin R, Pettersson L-G, Sterling H, Widell A, Bodemar G: Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas. Scand J Gastroenterol 27:443–448, 1992

    Google Scholar 

  47. Watanabe M, Ohkoshi S, Tawaraya H, Miyajima T, Shimotohno K, Kamimura T, Asakura H: Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission. Transfusion 34:125–129, 1994

    Google Scholar 

  48. Mattsson L, Grillner L, von Sydow M, Bergdahl S, Weiland O: Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden. Infection 19:309–312, 1992

    Google Scholar 

  49. Wang J-T, Wang T-H, Lin J-T, Sheu J-C, Sung J-L, Chen D-S: Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan. J Med Virol 32:83–86, 1990

    Google Scholar 

  50. Nishioka K, Watanabe J, Furuta S, Tanaka E, Suzuki H, Iino S, Tsuji T, Yano M, Kuo G, Choo Q-L, Houghton M, Oda T: Antibody to the hepatitis C virus in acute hepatitis and chronic liver disease in Japan. Liver 11:65–70, 1991

    Google Scholar 

  51. Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A, Ruol A: Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 114:277–281, 1991

    Google Scholar 

  52. Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Scholten E, Kremer LCM, Cuypers HTM, Lelis PN, van Oers MHJ: Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet 345:95–96, 1995

    Google Scholar 

  53. Ni Y-H, Chang M-H, Lue H-C, Hsu H-Y, Wang M-J, Chen P-J, Chen D-S: Posttransfusion hepatitis C virus infection in children. J Pediatr 124:709–713, 1994

    Google Scholar 

  54. Bortolloti F, Jara P, Diaz C, Vajro P, Hierro L, Giachino R, de la Vega A, Crivellaro C, Camarena C, Barbera C, Mebbia G, Zancan L, de Moliner L: Post transfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr 18:279–283, 1994

    Google Scholar 

  55. Lelie PN, Cuypers HT, Reesink HW, van der Poel CL, Winkel I, Bakker E, van Exel-Oehlers PJ, Vallari D, Allain JP, Mimms L: Patterns of serological markers in transfusion transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol 37:203–209, 1992

    Google Scholar 

  56. Laskus T, Cianciara J, Slusarczyk J: A follow-up study of an outbreak of non-A, non-B hepatitis in a plasmapheresis unit. Liver 10:49–53, 1990

    Google Scholar 

  57. Goncales FL Jr, Pedro R de J, da Silva LJ, Boccato RS, Goncales NS: Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates. Rev Inst Med Trop Sao Paulo 35:63–71, 1993 (in Portuguese)

    Google Scholar 

  58. Goncales FL Jr, Boccato RS, Pedro R de J, Papaiordanou PM, de Souza CA, Goncales NS, Pellegrino J Jr: Prevalence of HBsAG, anti-HBc and anti-HCV in blood donor candidates at the Campinas hemocenter. Rev Inst Med Trop Sao Paulo 35:45–51, 1993 (in Portuguese)

    Google Scholar 

  59. Ohto H, Nomura H, Ohmura K, Ishijima A, Okazaki S: Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C. Rinsho Byori 39:14–17, 1991 (in Japanese)

    Google Scholar 

  60. Kuperan P, Choon AT, Ding SH, Lee G: Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore. Southeast Asian J Trop Med Public Health 24(suppl 1):127–129, 1993

    Google Scholar 

  61. Richards C, Holland P, Kuramoto K, Douville C, Randell R: Prevalence of antibody to hepatitis C virus in a blood donor population. Transfusion 31:109–113, 1991

    Google Scholar 

  62. Wang Y-J, Lee S-D, Hwang S-J, Chan C-Y, Chow M-P, Lai S-T, Lo K-J: Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody. Vox Sang 67:187–190, 1994

    Google Scholar 

  63. Morris JA Jr, Wilcox TR, Reed GW, Hunter EB, Wallas CH, Steane EA, Shotts SD, Vitsky JL: Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion. Ann Surg 219:517–525, 1994

    Google Scholar 

  64. Norol F, Roche B, Girardin M-FSM, Kuentz M, Desforges L, Cordonnier C, Duedari N, Vernant J-P: Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 67:393–397, 1994

    Google Scholar 

  65. Jullien AM, Couroucé AM, Massari V, Maniez M, Finetti P, Brevière D, Girard M, Andréani T, Habibi B: Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis 12:668–672, 1993

    Google Scholar 

  66. Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Lelie PN: Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report. Vox Sang 68:55–56, 1995

    Google Scholar 

  67. Norol F, Bachir D, Bernaudin F, Beaujean F, Desforges L, Duedari N, Galacteros F: Frozen blood and transfusion-transmitted hepatitis C virus. Vox Sang 64:150–153, 1993

    Google Scholar 

  68. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger BF, Gitnick G, Knodell RG, Perillo RP, Stevens CE, Hollingsworth CDG, and the National Heart, Lung and Blood Institute Study Group: Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906–1911, 1992

    Google Scholar 

  69. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671–675, 1990

    Google Scholar 

  70. Tong MJ, el-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463–1466, 1995

    Google Scholar 

  71. Strasser SI, Watson KRJ, Lee CS, Coghlan PJ, Desmond PV: Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust 162:355–358, 1995

    Google Scholar 

  72. Wiese M: Spontanverlauf der Virushepatitis C—Langzeitprognose einer unselektierten Gruppe mit definierter Infection. Der Kassenartz 36–38, 1996

  73. Hino K, Sainokami S, Shimoda K, Niwa H, Iino S: Clinical course of acute hepatitis C and changes in HCV markers. Dig Dis Sci 39:19–27, 1994

    Google Scholar 

  74. Buti M, Jardi R, Rodriguez-Frias F, Quer J, Esteban R, Guardia J: Etiology of acute sporadic hepatitis in Spain: the role of hepatitis C and E viruses. J Hepatol 20:589–592, 1994

    Google Scholar 

  75. Diepolder HM, Zachoval R, Hoffman RM, Wierenga EA, Santantonio T, Jung M-C, Eichenlaub D, Pape GR: Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006–1007, 1995

    Google Scholar 

  76. Kao J-H, Tsai S-L, Chen P-J, Yang P-M, Sheu J-C, Lai M-Y, Hsu H-C, Sung J-L, Wang T-H, Chen D-S: A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: Comparison between posttransfusion and sporadic patients. J Hepatol 21:244–249, 1994

    Google Scholar 

  77. Gordon SC, Kodali VP, Silverman AL, Dmuchowski CF, Urdea MS, Chan CS, Wilber JC: Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 89:1458–1461, 1994

    Google Scholar 

  78. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC: Significance of hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501–1504, 1993

    Google Scholar 

  79. Neumayr G, Judmaier G, Stoffler G, Dietze O, Vogel W: The significance of infection pathways for hepatitis C virus infection associated with chronic liver disease. Z Gastroenterol 32:338–341, 1994 (in German)

    Google Scholar 

  80. Pereira BJG, Wright TL, Schmid CH, Levey AS, for the New England Organ Bank Hepatitis C Study Group: A controlled study of hepatitis C transmission by organ transplantation. Lancet 345:484–487, 1995

    Google Scholar 

  81. Wreghitt TG, Gray JJ, Allain J-P, Poulain J, Garson JA, Deaville R, Maple C, Parameshwar J, Calne RY, Wallwork J, Alexander GJM: Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 20:768–772, 1994

    Google Scholar 

  82. Shuhart MC, Myerson D, Childs BH, Fingeroth JD, Perry JJ, Snyder DS, Spurgeon CL, Bevan CA, McDonald GB: Marrow transplantation from hepatitis C virus seropositive donors: Transmission rate and clinical course. Blood 84:3229–3235, 1994

    Google Scholar 

  83. Conrad EU, Gretch DR, Obermeyer KR, Moogk MS, Sayers M, Wilson JJ, Strong DM: Transmission of hepatitis C virus by tissue transplantation. J Bone Joint Surg 77A:214–224, 1995

    Google Scholar 

  84. Kroes ACM, de Man RA, Niesters HGM, Schalm SW, Weimar W, Balk AHMM: Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. J Hepatol 21:1113–1115, 1994

    Google Scholar 

  85. Lim HL, Lau GKK, Davis GL, Dolson DL, Lau JYN: Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 106:248–251, 1994

    Google Scholar 

  86. Milfred SK, Lake KD, Anderson DJ, Hayney MS, Love KR, Emery RW, Pritzker MR: Practices of cardiothoracic transplant centers regarding hepatitis C-seropositive candidates and donors. Transplantation 57:568–572, 1994

    Google Scholar 

  87. Cadranel JF, Grippon P, Lunel F, Desruennes M, Leger P, Azar N, Moussalli J, Pauwels A, Cabrol A, Salmon P, Charpentier YL, Cabrol C, Huraux JM, Opolon P: Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. A retrospective study in 80 patients with follow-up of 60 months. Transplantation 52:645–650, 1991

    Google Scholar 

  88. Kanamori H, Fukawa H, Maruta A, Harano H, Kodama F, Matsuzaki M, Miyashita H, Motomura S, Okuba T, Yoshiba M, Sekiyama K: Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation. Am J Med Sci 303:109–111, 1992

    Google Scholar 

  89. Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM: Withdraw of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 8:417–420, 1991

    Google Scholar 

  90. Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O: Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm. Scand J Gastroenterol 29:360–362, 1994

    Google Scholar 

  91. Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC: Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 153:1705–1712, 1993

    Google Scholar 

  92. Campello C, Majori S, Poli A, Pacini P, Nicolardi L, Pini F: Prevalence of HCV antibodies in health-care workers from northern Italy. Infection 20:224–226, 1992

    Google Scholar 

  93. Klein RS, Freeman K, Taylor PE, Stevens CE: Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 338:1539–1542, 1991

    Google Scholar 

  94. Goetz AM, Ndimbie OK, Wagener MM, Muder RR: Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center. Transplantation 59:990–994, 1995

    Google Scholar 

  95. Hasebe C, van Thiel RC, Eygendaal D, Chung RT, Dienstag JL, Kaplan LM: Primary screening for viral RNA by “iterative PCR” reveals a significantly increased prevalence of hepatitis C virus (HCV) infection in health workers. Hepatology 16:72A, 1992 (abstract)

    Google Scholar 

  96. Zuckerman J, Clewley G, Griffiths P, Cockcroft A: Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet 343:1618–1620, 1994

    Google Scholar 

  97. De Brouwer C, Lecomte A: HCV antibodies in clinical health-care workers. Lancet 344:962, 1994 (letter)

    Google Scholar 

  98. Frider B, Sookoian S, Castano G, Rebora N, Gutfraind Z, Mirta K, Veyretou F, Wainstein C: Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays. Acta Gastroenterol Latinoam 24:71–75, 1994

    Google Scholar 

  99. Ishiguro N, Tomimatsu M, Nagahara H, Obata H: Clinical evaluation of a newly established anti-HCV assay for the diagnosis of hepatitis C in Japan. J Gastroenterol Hepatol 7:602–607, 1992

    Google Scholar 

  100. Estaban JJ, Gomez J, Martell M, Cabot B, Quer J, Camps J, Gonzalez A, Otero T, Moya A, Esteban R: Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 334:555–560, 1995

    Google Scholar 

  101. Homma S, Toshima K, Shima H, Inadama E, Sato C, Kuwano T, Sato Y, Toda G: HCV viremia immediately after accidental needle stick. Int Hepatol Commun 2/3:166–169, 1994

    Google Scholar 

  102. Sodeyama T, Kiyosawa K, Urushihara A, Matsumoto A, Tanaka E, Furuta S, Akahane Y: Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch Intern Med 153:1565–1572, 1993

    Google Scholar 

  103. Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F, Tanaka T, Mishiro S: Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16:1109–1114, 1992

    Google Scholar 

  104. Francavilla E, Rinaldi R, Cattelan AM, Vicariotto M, Botolotti F, Cadrobbi P: Low prevalence of antibodies to hepatitis C virus in hospital employees. Infection 20:295, 1992

    Google Scholar 

  105. Suzuki K, Mizokami M, Lau JYN, Mizoguchi N, Kato K, Mizuno Y, Sodeyama T, Kiyosawa K, Gojobori T: Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis 170:1575–1578, 1994

    Google Scholar 

  106. Gerberding JL: Management of occupational exposures to blood-borne viruses. N Engl J Med 332:444–451, 1995

    Google Scholar 

  107. al-Khaja N, Roberts DG, Belboul A, Lopere V, Bergman P, Radberg G, Hermodsson S, Olssen RG: Gamma globulin prophylaxis to reduce post-transfusion non-A, non-B hepatitis after cardiac surgery with cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 25:7–12, 1991

    Google Scholar 

  108. Seeff LB, Zimmerman HJ, Wright EC, Finkelstein JD, Gracia-Pont P, Greenlee HB, Dietz AA, Leevy CM, Tamburro CH, Schiff ER, Schimmel EM, Zemel R, Zimmon DS, Mc-Collum RW: A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology 72:111–121, 1977

    Google Scholar 

  109. Knodell RG, Conrad ME, Ishak KG: Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of γ-globulin prophylaxis and its prevention. Gastroenterology 72:902–909, 1977

    Google Scholar 

  110. Sanchez-Quijano A, Pineda JA, Lissen E, Leal M, Diaz-Torres MA, Garcia de Pesquera F, Rivera F, Castro R, Muūnoz J: Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1:1245–1249, 1988

    Google Scholar 

  111. Moaven LD, Locarnini SA, Schiff P: Passive immunisation against hepatitis C infection. Med J Aust 158:358, 1993 (letter)

    Google Scholar 

  112. Lanphear BP, Linnemann CC, Cannon CG, DeRonde MM, Pendy L, Kerley LM: Hepatitis C virus infection in health care workers: Risk of exposure and infection. Infect Control Hosp Epidemiol 15:745–750, 1994

    Google Scholar 

  113. Marranconi F, Mecenero V, Pellizzer GP, Bettini MC, Conforto M, Vaglia A, Stecca C, Cardone E, de Lalla F: HCV infection after accidental needlestick injury in health-care workers. Infection 20:111, 1992 (letter)

    Google Scholar 

  114. Laufs R, Polywka S, Feucht HH, Ebeling M, Iske L, Friedrich K, Oehler G, Keitel M, Nolte H, Thiele B: “Was bedeutet der Befund “HCV-Antikörper positiv?” Dtsch Ärzteblatt 91:A285–287, 1994

    Google Scholar 

  115. Inoue Y, Miyamura T, Unayama T, Takahashi K, Saito I: Maternal transfer of HCV. Nature 353:609, 1991 (letter)

    Google Scholar 

  116. Weiner AJ, Thaler MM, Crawford K, Ching K, Kansopon J, Chien DY, Hall JE, Hu F, Houghton M: A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 67:4365–4368, 1993

    Google Scholar 

  117. Ni Y-H, Lin H-H, Chen P-J, Hsu H-Y, Chen D-S, Chang M-H: Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immunodeficiency virus coinfection. J Hepatol 20:641–645, 1994

    Google Scholar 

  118. Lin HH, Hsu HY, Lee TY, Kao JH, Chen PJ, Chen DS: Hepatitis C virus infection in pregnant women: detection by different anti-HCV immunoassays and serum HCV-RNA. Asia Oceania J Obstet Gynaecol 20:13–18, 1994

    Google Scholar 

  119. Lin H-H, Kao J-H, Hsu H-Y, Ni Y-H, Yeh S-H, Hwang L-H, Chang M-H, Hwang S-C, Chen P-J, Chen D-S: Possible role of high-titer maternal viremia inperinatal transmission of hepatitis C virus. J Infect Dis 169:638–641, 1994

    Google Scholar 

  120. Ohto H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A, Okamoto H, Mishiro S, and the Vertical Transmission of Hepatitis C Virus Collaborative Study Group: Transmission of hepatitis C virus from mothers to infants. N Engl J Med 330:744–750, 1994

    Google Scholar 

  121. Manzini P, Saracco G, Cerchier A, Riva C, Musso A, Ricotti E, Palomba E, Scolfaro C, Verme G, Bonino F, Tovo PA: Human immunodeficiency virus infection at risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 21:328–332, 1995

    Google Scholar 

  122. Roudot-Thoraval F, Pawlotsky J-M, Thiers V, Deforges L, Girollet P-P, Guillot F, Huraux C, Aumont P, Brechot C, Dhumeaux D: Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: A prospective study with hepatitis C virus RNA testing. Hepatology 17:772–777, 1993

    Google Scholar 

  123. Lam JPH, McOmish F, Burns SM, Yap PL, Mok JYQ, Simmonds P: Infrequent vertrical transmission of hepatitis C virus. J Infect Dis 167:572–576, 1993

    Google Scholar 

  124. Wejstål R, Widell A, Månsson A-S, Hermodsson S, Norkrans G: Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 117:887–890, 1992

    Google Scholar 

  125. Reinus JF, Leikin EL, Alter HJ, Cheung L, Shindo M, Jett B, Piazza S, Shih JW-K: Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 117:881–886, 1992

    Google Scholar 

  126. Wejstål R, Hermodsson S, Iwarson S, Norkrans G: Mother to infant transmission of hepatitis C virus infection. J Med Virol 30:178–180, 1990

    Google Scholar 

  127. Marcellin P, Bernuau J, Martinot-Peignoux M, Larzul D, Li-Zhe-Xu, Erlinger S, Benhamou JP: Risk for mother-to-infant transmission of HCV in asymptomatic anti-HCV positive women. Gastroenterology 102:A848, 1992 (abstract)

  128. Kurauchi O, Furui T, Itakura A, Ishiko H, Sugiyama M, Ohno Y, Ando H, Tanamura A, Ishida T, Nawa A, Nomura S, Mizutani S, Tomoda Y: Studies on transmission of hepatitis C virus from mother-to-child in the perinatal period. Arch Gynecol Obstet 253:121–126, 1993

    Google Scholar 

  129. Uehara S, Abe Y, Saito T, Yoshida Y, Wagatsuma S, Okamura K, Yajima A, Mandai M: The incidence of vertical transmission of hepatitis C virus. Tohoku J Exp Med 171:195–202, 1993

    Google Scholar 

  130. Thaler MM, Park C-K, Landers DV, Wara DW, Houghton M, Veereman-Wauters G, Sweet RL, Han JH: Vertical transmission of hepatitis C virus. Lancet 338:17–18, 1991

    Google Scholar 

  131. Novati R, Thiers V, Monforte AD, Maisonneuve P, Principi N, Conti M, Lazzarin A, Brechot C: Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis 165:720–723, 1992

    Google Scholar 

  132. Giovannini M, Tagger A, Ribero ML, Zuccotti G, Pogliani L, Grossi A, Ferroni P, Fiocchi A: Maternal-infant transmission of hepatitis C virus and HIV infections: A possible interaction. Lancet 335:1166, 1990 (letter)

    Google Scholar 

  133. Weintrub PS, Veereman-Wauters GL, Cowan MJ, Thaler MM: Hepatitis C virus infection in infants whose mothers took street drugs intravenously. J Pediatr 119:869–874, 1991

    Google Scholar 

  134. Lin H-H, Kao J-H, Hsu H-Y, Ni Y-H, Chang M-H, Huang S-C, Hwang L-H, Chen P-J, Chen D-S: Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 126:589–591, 1995

    Google Scholar 

  135. European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet 339:1007–1012, 1992

    Google Scholar 

  136. Peckham C, Gibb D: Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 333:298–302, 1995

    Google Scholar 

  137. European Collaborative Study: Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 343:1464–1467, 1994

    Google Scholar 

  138. Boyer PJ, Dillon M, Navaie M, Deveikis A, Keller M, O'Rourke S, Bryson YJ: Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 271:1925–1930, 1994

    Google Scholar 

  139. Umlauft F, König P, Weyrer K, Grünewald K, Vogel W: Hepatitis C virus infection in patients on maintenance hemodialysis. Hepatology 16:224A, 1992 (abstract)

    Google Scholar 

  140. Sakamoto N, Enomoto N, Marumo F, Sato C: Prevalence of hepatitis C virus infection among long-term hemodialysis patients: Detection of hepatitis C virus RNA in plasma. J Med Virol 39:11–15, 1993

    Google Scholar 

  141. Hussein MM, Mooij JMV, Roujouleh H, El Sayed H: Observations in a Saudi-Arabian dialysis population over a 13-year period. Nephrol Dial Transplant 9:1072–1076, 1994

    Google Scholar 

  142. Dussol B, Berthezène P, Brunet P, Roubicek C, Berland Y: Hepatitis C virus infection among chronic dialysis patients in the South of France: A collaborative study. Am J Kidney Dis 25:399–404, 1995

    Google Scholar 

  143. Ng Y-Y, Lee S-D, Wu S-C, Yang W-C, Chiang S-S, Huang T-P: Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 35:263–266, 1991

    Google Scholar 

  144. Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Crepaldi M, Pagano A, Locatelli F: Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: A prospective study. Nephrol Dial Transplant 9:1611–1615, 1994

    Google Scholar 

  145. Dienstag JL, Stevens CE, Szmuness W: The epidemiology of non-A, non-B hepatitis: emerging patterns.In Non-A, Non-B Hepatitis. RJ Gerety (ed). New York, Academic Press, 1981, pp 119–138

    Google Scholar 

  146. Lok ASF, Chan TM, Chan R, Cheng IKP: HCV infection in hemodialysis (HD) patients: A comparative study using 1st and 2nd generation EIA for anti-HCV and PCR for HCV-RNA. Gastroenterology 102:A845, 1992 (abstract)

  147. Cahn TM, Lok ASF, Cheng IKP, Chan RT: Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 17:5–8, 1993

    Google Scholar 

  148. Jadoul M, Cornu C, van Ypersele de Strihou C, and the UCL Collaborative Group: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. Kidney Int 44:1322–1326, 1993

    Google Scholar 

  149. Pol S, Romeo R, Zins B, Lebkiri B, Berthelot P, Bréchot C: High frequency of HCV viremia in antiHCV positive hemodialyzed patients. Hepatology 16:218A, 1992 (abstract)

    Google Scholar 

  150. Gerritzen A, Klehr U, Scholt B, Kaiser R, Lutzke G, Ferber J, Schneweis KE: Infektionsrisiko durch Hepatitis C virus bei der Hämodialyse. Klin Woschenr 69(suppl 28):36, 1992 (abstract)

    Google Scholar 

  151. Alter MJ: Epidemiology of hepatitis C in the West. Semin Liver Dis 15:5–14, 1995

    Google Scholar 

  152. Neal KR, Jones DA, Killey D, James V: Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Epidemiol Infect 112:595–601, 1994

    Google Scholar 

  153. Marranconi F, Fabris P, Stecca C, Zampieri L, Bettini MC, De Fabrizio N, de Lalla F: Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women. Infection 22:333–337, 1994

    Google Scholar 

  154. Allander T, Gruber A, Naghavi M, Beyene A, Soderstrom T, Bjorkholm M, Grillner L, Persson MA: Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345:603–607, 1995

    Google Scholar 

  155. Rey JF, Halfon P, Feryn JM, Khiri H, Masseyeff MF, Ouzan D: Risque de transmission du virus de l'hepatite C par l'endoscopie digestive. Gastroenterol Clin Biol 19:346–349, 1995

    Google Scholar 

  156. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, Nakano Y, Usuda S, Uemura K, Furuta S, Watanabe Y, Watanabe J, Fukuda Y, Takayama T, and the South Kiso Hepatitis Study Group: Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection. Gastroenterology 106:1596–1602, 1994

    Google Scholar 

  157. Mele A, Sagliocca L, Manzillo G, Converti F, Amoroso P, Stazi MA, Ferrigno L, Rapicetta M, Franco E, Adamo B, Palumbo F, Sbreglia C, Paná A, Pasquini P, and the SEIEVA Collaborating Group: Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: A case-control study. Am J Public Health 84:1640–1643, 1994

    Google Scholar 

  158. Piazza M, Borgia G, Picciotto L, Nappa S, Cicciarello S, Orlando R: Detection of hepatitis C virus-RNA by polymerase chain reaction in dental surgeries. J Med Virol 45:40–42, 1995

    Google Scholar 

  159. Abe K, Inchauspe G: Transmission of hepatitis C by saliva. Lancet 337:248, 1991 (letter)

    Google Scholar 

  160. Abe K, Kurata T, Shikata T, Sugitani M, Oda T: Experimental transmission of non-A, non-B hepatitis by saliva. J Infect Dis 155:1078–1079, 1987

    Google Scholar 

  161. Wang J-T, Wang T-H, Lin J-T, Sheu J-C, Lin S-M, Chen D-S: Hepatitis C virus RNA in saliva of patients with post-transfusion hepatitis C infection. Lancet 337:48, 1991 (letter)

    Google Scholar 

  162. Takamatsu K, Koyanagi Y, Okita K, Yamamoto N: Hepatitis C virus in saliva. Lancet 336:1515, 1990 (letter)

    Google Scholar 

  163. Couzigou P, Richard L, Dumas F, Schouler L, Fleury H: Detection of virus C RNA in saliva of patients with chronic hepatitis C. Gastroenterology 102:A795, 1992 (abstract)

    Google Scholar 

  164. Dusheiko GM, Smith M, Scheuer PJ: Hepatitis C virus transmitted by human bite. Lancet 336:503–504, 1990 (letter)

    Google Scholar 

  165. Riestra Menédez S, Rodríiguez García M, Sánchez San Román F, Menéndez Tévar F, Suárez Gonzalez A, Alvarez Navascués C, Pérez Alvarez R, Rodrigo Aáez L: Intrafamilial spread of hepatitis C. Infection 19:431–433, 1991

    Google Scholar 

  166. Tumminelli F, Marcellin P, Rizzo S, Barbera S, Corvino G, Furia P, Benhamou JP, Erlinger S: Shaving as potential source of hepatitis C virus infection. Lancet 345:658, 1995 (letter)

    Google Scholar 

  167. Gordon SC, Patel AH, Kulesza GW, Barnes RE, Silverman AL: Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 87:1849–1851, 1992

    Google Scholar 

  168. Napoli N, Fiore G, Vella F, Fera G, Schiraldi O: Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C. Eur J Epidemiol 9:629–632, 1993

    Google Scholar 

  169. Chang T-T, Liou T-C, Young K-C, Lin X-Z, Lin C-Y, Shin J-S, Wu H-L: Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 42:91–96, 1994

    Google Scholar 

  170. Kiyosawa K, Sodeyama T, Tanaka E, Shimizu S, Furuta S, Miyazaki Y, Akhane Y, Suzuki H: Intrafamilial transmission of hepatitis C virus in Japan. J Med Virol 33:114–116, 1991

    Google Scholar 

  171. Mondello P, Patti S, Vitale MG, D'Accardo AM, Spanó C: Anti-HCV antibodies in household contacts of patients with cirrhosis of the liver—preliminary results. Infection 20:51–52, 1992 (letter)

    Google Scholar 

  172. Kaplan AJ, Zone-Smith LK, Hannegan C, Norcross ED: The prevalence of hepatitis C in a regional level 1 trauma center population. J Trauma 33:126–128, 1992

    Google Scholar 

  173. Crofts N, Steward T, Hearne P, Ping XY, Breschkin AM, Locarnini SA: Spread of bloodborne viruses among Australian prison entrants. Br Med J 31:285–288, 1995

    Google Scholar 

  174. Thomas DL, Mahley RW, Badur S, Palaoglu E, Quinn TC: The epidemiology of hepatitis C in Turkey. Infection 22:411–414, 1994

    Google Scholar 

  175. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ, for the Multicenter Hemophilia Cohort Study: Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood 84:1020–1023, 1994

    Google Scholar 

  176. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Piette JC, Huraux J-M, Opolon P: Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 106:1291–1300, 1994

    Google Scholar 

  177. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465–470, 1993

    Google Scholar 

  178. Doutrelepont J-M, Adler M, Willems M, Durez P, Yap S-H: Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet 341:317, 1993 (letter)

    Google Scholar 

  179. Harlé J-R, Disdier P, Dussol B, Bolla G, Casanova P, Weiller P-J: Membranoproliferative glomerulonephritis and hepatitis C infection. Lancet 341:904, 1993 (letter)

    Google Scholar 

  180. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490–1495, 1992

    Google Scholar 

  181. Ferri C, Zignego AL, Longombardo G, Monti M, La Civita L, Lombardini F, Greco F, Mazzoni A, Pasero G, Gentilini P, Bombardieri S, Manns M: Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients. Infection 21:93–97, 1993

    Google Scholar 

  182. Bonomo L, Casato M, Afeltra A, Caccavo D: Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 83:726–730, 1987

    Google Scholar 

  183. Bibas M, Andriani A: Hepatitis C virus and cryglobulinaemia. N Engl J Med 328:1123, 1993 (letter)

    Google Scholar 

  184. Marcellin P, Descamps V, Martinot-Peignoux M, Larzul D, Xu L, Booyer M, Pham BN, Crickx B, Guillevin L, Belaich S, Erlinger S, Benhamou JP: Cryoglobulinaemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 104:272–277, 1993

    Google Scholar 

  185. D'Amico G, Fornasieri A: Cryoglobulinemic glomerulonephritis: A membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 25:361–369, 1995

    Google Scholar 

  186. Hartwell P, Willson R, Hart J, Johnson R: Chronic hepatitis C, glomerulonephritis, and alpha interferon-2b. Gastroenterology 102:A818, 1992 (abstract)

    Google Scholar 

  187. Johnson RJ, Gretch DR, Conser WG, Alpers CE, Wilson J, Chung M, Hart J, Willson R: Hepatitis C virus-associated glomerulonephritis. Effect ofα-interferon therapy. Kidney Int 46:1700–1704, 1994

    Google Scholar 

  188. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Régnier D, Beusnel C, Sadoul JL, Hébuterne X, Rampel P: High prevalence of Hashimoto's thyroiditis in female patients with chronic hepatitis C prior to treatment by interferon. Gastroenterology 104(suppl):A1011, 1993 (abstract)

    Google Scholar 

  189. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Regnier D, Dreyfus G, Pradier C, Sadoul J-L, Hébuterne X, Rampel P: High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18:1253–1257, 1993

    Google Scholar 

  190. Marcellin P, Pouteau M, Renard P, Grynblat J-M, Linhardt NC, Bardet P, Bok B, Benhamou J-P: Sustained hypothyroidism induced by recombinantα interferon in patients with chronic hepatitis C. Gut 33:855–856, 1993

    Google Scholar 

  191. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 102:2155–2160, 1992

    Google Scholar 

  192. Pawlotsky JM, Ben Yahia M, André C, Voisin MC, Intrator L, Deforges L, Duvoux C, Zafrani ES, Duval J, Dhumeaux D: Immunological disorders associated with C viral chronic hepatitis: A prospective evaluation. Hepatology 16:217A, 1992 (abstract)

    Google Scholar 

  193. Haddad J, Deny P, Munz-Gotheil C, Ambrosini J-C, Trinchet J-C, Pateron D, Mal F, Callard P, Beaugrand M: Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321–323, 1992

    Google Scholar 

  194. King PD, McMurray RW, Becherer PR: Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 89:1047–1050, 1994

    Google Scholar 

  195. Pawlotsky JM, Benchiki H, Pellet C, Duval J, Dhumeaux D, Revuz J, Bagot M: Lichen planus and hepatitis C virus (HCV)-related chronic hepatitis: evaluation of HCV genotypes. Br J Dermatol 133:666–667, 1995 (letter)

    Google Scholar 

  196. Allison MED, Wreghitt T, Plamer CR, Alexander GJ: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 21:1135–1139, 1994

    Google Scholar 

  197. Cacoub P, Lunel-Fabiani F, Houng Du LT: Polyarteriitis nodosa and hepatitis C virus infection. Ann Intern Med 116:605–606, 1992

    Google Scholar 

  198. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME: Frequency and significance of antibodies to hepatitis C virus in polyarteriitis nodosa. J Rheumatol 20:304–309, 1993

    Google Scholar 

  199. Fargion S, Piperno A, Capellini MD, Sampietro M, Fracanzani AL, Romano R, Calderelli R, Marcelli R, Vecchi L, Fiorelli G: Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 16:1322–1326, 1992

    Google Scholar 

  200. DeCastro M, Sánchez J, Herrera JF, Cháves A, Durán R, García-Buey L, García-Monzón C, Sequí J, Moreno-Otero R: Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 17:551–557, 1993

    Google Scholar 

  201. Ferri C, Baicchi U, La Civita L, Greco F, Longombardo G, Mazzoni A, Careccia G, Bombardieri S, Pasero G, Zignego AL, Manns MP: Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 23:851–855, 1993

    Google Scholar 

  202. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, Terés J, Mascaró JM, Rodés J: Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 341:788–789, 1993

    Google Scholar 

  203. Stölzel U, Köstler E, Koszka C, Stöffler-Meilicke M, Schuppan D, Somasundaram R, Doss MO, Habermehl KO, Riecken EO: Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 21:1500–1503, 1995

    Google Scholar 

  204. Murphy A, Dooley S, Hillary IB, Murphy GM: HCV infection in porphyria cutanea tarda. Lancet 341:1534–1535, (letter)

  205. Perrillo RP, Pohl DA, Roodman ST, Tsai CC: Acute non-A, non-B hepatitis with serum sickness-like syndrome and aplastic anemia. JAMA 245:495–496, 1981

    Google Scholar 

  206. Zeldis JB, Dienstag JL, Gale RP: Aplastic anemia and non-A, non-B hepatitis. Am J Med 74:64–68, 1983

    Google Scholar 

  207. Pol S, Driss F, Devergie A, Brechot C, Berthelot P, Gluckman B: Is hepatitis C virus involved in hepatitis-associated aplastic anemia? Ann Intern Med 113:435–437, 1990

    Google Scholar 

  208. Hibbs JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, Locasciulli A, Tzakis AG, Alter HJ, Young NS: Aplastic anemia and viral hepatitis. Non-A, non-B, non-C? JAMA 267:2051–2054, 1992

    Google Scholar 

  209. Pol S, Thiers V, Driss F, Devergie A, Berthelot P, Brechot C, Gluckman E: Lack of evidence for a role of HCV in hepatitis-associated aplastic anemia. Br J Haematol 85:808–810, 1993

    Google Scholar 

  210. Strassburg CP, Manns MP: Autoimmune hepatitis versus viral hepatitis C. Liver 15:225–232, 1995

    Google Scholar 

  211. Ruis-Moreno M, Rúa MJ, Carreño V, Quiroga JA, Manns M, Meyer zum Büschenfelde K-H: Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children. J Hepatol 12:265–266, 1991 (letter)

    Google Scholar 

  212. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou J-P: Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 116:51–53, 1992

    Google Scholar 

  213. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613–619, 1995

    Google Scholar 

  214. Manns M, Scheucher S, Jentsch M, Broly F, Goergen B, Schneider P, Gerken G, Rittner Ch, Meyer zum Büschenfeld K-H, Meyer UA: Genetics in autoimmune hepatitis type 2. Hepatology 14:60A, 1991 (abstract)

  215. Lenzi M, Mantovani W, Cataleta M, Ballardini G, Cassani F, Giostra F, Muratori L, Bianchi FB: HLA-typing in autoimmune hepatitis (AI-CAH) type 2. J Hepatol 16(suppl 1):S59, 1992

    Google Scholar 

  216. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108:157–164, 1995

    Google Scholar 

  217. Verdon R, Pol S, Landais P, Mattlinger B, Carnot F, Brechot C, Busson M, Kreis H: Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialized patients. J Hepatol 21:388–393, 1994

    Google Scholar 

  218. Vitte RL, Fortier C, Richardet JP, Grimbert S, Trinchet JC, Beaugran M, Lepage V, Raffoux C: HLA antigens in patients with chronic hepatitis C. Tissue Antigens 45:356–361, 1995

    Google Scholar 

  219. Peano G, Menardi G, Ponzetto A, Fenoglio LM: HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 154:2733–2736, 1994

    Google Scholar 

  220. Silverman AL, Puccio JE, Kulesza GW, McCray DG, Gordon SC: HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection. Am J Gastroenterol 89:1201–1202, 1994

    Google Scholar 

  221. Choo Q-L, Kuo G, Ralson R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopou J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E: Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 91:1294–1298, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Gastroenterology and Hepatology, Zentrum für Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, 30623, Hannover, Germany

    Hans L. Tillmann & Michael P. Manns Dr. (Professor)

Authors
  1. Hans L. Tillmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael P. Manns Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tillmann, H.L., Manns, M.P. Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Digest Dis Sci 41 (Suppl 12), 27S–40S (1996). https://doi.org/10.1007/BF02087874

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02087874

Key words

Search

Navigation